Health Sciences Authority (HSA) — Singapore's Medical Device Regulator
The Health Sciences Authority (HSA) regulates medical devices in Singapore under the Health Products Act (Chapter 122D) and the Health Products (Medical Devices) Regulations 2010. All Class B, C, and D devices must be registered in the Singapore Medical Device Register (SMDR) before they can be placed on the market.
Class A devices are exempt from product registration but still require a licensed dealer (importer or local manufacturer) who holds a valid Dealer's Licence. In practice, every device entering the Singapore market requires a locally registered Registrant or License Holder — either the manufacturer, an authorized agent, or an independent entity such as JNPMEDI APAC.
HSA evaluates devices via four registration routes: Immediate (Class A), Abridged and Expedited (Class B), and Full or Abridged (Class C and D). Devices with CE marking, FDA 510(k)/PMA, TGA, or equivalent approvals may qualify for the Abridged or Expedited pathways, significantly reducing review time.
- Singapore Medical Device Register (SMDR) — HSA online portal submission
- Dealer's Licence required for importers and local manufacturers
- Post-market obligations: incident reporting, field safety corrective actions, PMS
- GDPMDS (Good Distribution Practice for Medical Devices) mandatory for distributors
- Annual licence renewal and variation management required
HSA Review Timelines by Device Class
Target review times from submission acceptance date — excluding deficiency response periods.
Integrated Services for Singapore HSA Registration
HSA Device Registration
End-to-end management of HSA submissions for Class A–D — dossier preparation, SMDR portal submission, deficiency response, and approval tracking. Full, Abridged, and Expedited pathways. IVD, SaMD, and wireless device compliance included.
Independent License Holding (MAH)
JNPMEDI APAC acts as your independent Singapore Registrant — structurally separate from your distributor. Change commercial partners freely without re-registration. Full compliance maintenance, variation management, and renewal included.
Post-Market & PMS
Post-approval compliance: HSA incident reporting, field safety corrective actions, product recalls, PMS program design, and GDPMDS distribution compliance — ensuring your device stays compliant throughout its commercial life.
Why JNPMEDI APAC for Singapore HSA Registration
We are registered in Singapore and serve as your on-the-ground Registrant. Unlike purely administrative license holders, we understand your product's clinical and scientific profile — so we can defend dossiers, respond to HSA deficiencies, and manage post-market obligations with genuine expertise.
JNPMEDI APAC holds zero distributor equity. Your license is never tied to a distribution partner, meaning you can change commercial arrangements freely — without re-registration delays, license transfer costs, or regulatory disruption.
Singapore is the APAC gateway, but most manufacturers need regional coverage. JNPMEDI APAC operates directly in 8 APAC markets — once your Singapore registration is secured, we can coordinate simultaneous submissions in Malaysia, Indonesia, Vietnam, Thailand, and India under the same platform.
Singapore HSA Registration — FAQ
Yes. HSA requires a locally incorporated entity to act as the Product Registrant for Class B, C, and D devices, or as the Dealer's Licence holder for Class A. Foreign manufacturers cannot hold registrations directly. JNPMEDI APAC serves as your Singapore-registered Registrant and License Holder, removing the need to establish your own subsidiary at the outset.
The License Holder (Registrant) is the entity registered with HSA as legally responsible for the product's regulatory compliance — including post-market obligations. The distributor is the commercial entity that imports and sells the product. Keeping these roles structurally separate means you can change distribution partners at any time without triggering re-registration, protecting both your regulatory standing and commercial flexibility.
HSA Class C devices are reviewed via the Abridged route (~240 days) or Full route (~255 days), measured from submission acceptance. These timelines exclude any deficiency response periods — which can add 30–90 days depending on the complexity of queries. JNPMEDI APAC manages the full submission cycle to minimize delays.
Yes. JNPMEDI APAC coordinates simultaneous registrations across Singapore, Malaysia, Indonesia, Vietnam, Thailand, and India under a single contract. This eliminates the need to manage multiple local regulatory partners separately and allows your dossier preparation work to be shared efficiently across markets.
Good Distribution Practice for Medical Devices (GDPMDS) is HSA's standard for the storage, handling, and distribution of medical devices in Singapore. It applies to all licensed dealers — importers, distributors, and wholesalers. JNPMEDI APAC provides GDPMDS compliance support including distribution agreement review, warehouse audit coordination, and ongoing compliance monitoring.